Once the transaction is finalized, the combined entity will go by the name HeartFlow Group and be listed on the New York Stock Exchange as “HFLO.”

HHS recently warned some 130 healthcare organizations are running vulnerable systems, potentially exposing millions of patients to danger.

Relying solely on transvaginal ultrasound in this population is often not enough to guide biopsy decision making, University of Washington Medicine oncologists wrote.

Hoping to shed new light on the debate between DOACs and VKAs, researchers in France examined data from more than 24,000 TAVR patients.

The experimental diagnostic method combines imaging and machine learning to seek patterns in functional connectivity and brain structure data. 

Not so fast with explainable AI in healthcare, warns an international and multidisciplinary team of academics.

Corporations own half of U.S. medical practices, with PE and similar stakeholders producing the sharpest increase (32%) in acquisitions between 2019-2020.

Nanopeptisomes bind to the surface of clots and point directly to where blockages are forming.

The 3-in-1 offering includes an introducer sheath, positioning balloon and RF puncture dilator.

Updating the imaging standard of care to include artificial intelligence as a second reader is one solution that takes some burden off individual physicians.